MIRA Pharmaceuticals (MIRA)

• Market cap: $63.2M
• 1 day: -4.43%
• 5 days: -7.36%
• 1 month: 2.72%
• 3 months: 14.39%
• 6 months: 24.79%
• Year to date: 31.3%
• 1 year: 25.83%
• 5 years: -79.65%
• 10 years: -79.65%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Employees: 5